• Sign in
NCCIH



×

NOTE

The NaPDI repository is currently a work in progress.
The current contents do not reflect a final product.

  • Database Home
  • Compounds
  • cannabidiol-2'-monomethyl ether
  • Home
  • Natural Products
  • Studies
  • Compounds
  • NaPDI Website

cannabidiol-2'-monomethyl ether

Need public description.

Compound information managed by NaPDI


None listed

None listed

None listed

None listed
  • Used in experiments 2
  • Used in studies 2
  • Download all
ID Subject of Study Study Name Name Type Overall Effect Enzymes Transporters Object Object Metabolite Precipitant
NPDI-DqfMEw Cannabis (Cannabis sativa) Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol Cannbidiol-2'-monomethyl ether In Vitro Enzyme Inhibition positive — In Vitro Enzyme Inhibition
  • CYP1A1
7-ethoxyresorufin resorufin cannabidiol-2'-monomethyl ether
NPDI-E6xHTA Cannabis (Cannabis sativa) Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety. Cannabidiol-2'-monomethyl ether In Vitro Enzyme Inhibition positive — In Vitro Enzyme Inhibition
  • CYP1A1
7-ethoxyresorufin resorufin cannabidiol-2'-monomethyl ether
ID Subject of Study Name
NPDI-Z6vbAA Cannabis (Cannabis sativa) Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol
NPDI-Ujn_7A Cannabis (Cannabis sativa) Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.

External Resources




  • NIH
  • NCCIH
  • NCCIH grant
  • Terms of Use

views/public/compound/view.ejs